This is investment research, not personal financial advice.
Nostrum Oil & Gas (LSE:NOG) fell 37.5% on Monday, from 4.0p to 2.5p, after agreeing to divest its Kazakhstan operating companies for US$304.6 million and wind down the listed group. The announcement carried a sentence more important than the headline consideration: the board does not expect material amounts to remain for shareholders after creditor repayments and the orderly wind-down (Nostrum 2026a; LSE 2026).
The percentage fall looks extreme. The creditor arithmetic is harsher. At 30 June, Nostrum had US$761.9 million of notes payable and US$154.4 million of unrestricted cash. Net debt was therefore about US$607.5 million. Even if the sale delivers its full headline price and every dollar of cash can be used, the stack is still short by roughly US$302.9 million before transaction costs, tax, working-capital adjustments and wind-down expenses. Independent deal coverage confirmed the buyer, price and creditor-led use of proceeds (DealFlow Intel 2026).
My reaction verdict is that the fall is justified and may still understate the destruction of ordinary-equity value. That does not mean 2.5p is irrational. Trading volume was only 653,467 shares, roughly £16,000 at the close, and the £4.1 million quoted equity can function as a thin option on a failed deal, a competing proposal or a large creditor concession. It is not a pro-rata claim on US$304.6 million. Bondholders stand first.
The sale price answers less than the creditor waterfall
GR Fairy Investments, a special-purpose vehicle beneficially owned by a Kazakh investor, agreed to acquire Nostrum's four Kazakhstan operating companies: Zhaikmunai LLP, Positive Invest LLP, Nostrum Oil & Gas Kazakhstan LLP and Nostrum Services Central Asia LLP. Those entities contain the producing Chinarevskoye field, the Stepnoy Leopard development position, the gas treatment facility and the people, permits and contracts needed to run them. The listed UK parent is selling the operating business, not a minority interest.
The consideration is US$304.6 million, subject to customary completion adjustments. Nostrum said it would use net cash proceeds together with existing cash reserves to repay the senior secured notes in full, repay US$150 million of senior unsecured notes, fund the unsecured-note tender announced on 24 July, and pay wind-down costs. The board expects the company to enter an orderly wind-down after completion, with no material amount left for ordinary shareholders. Completion requires regulatory approvals, lender consent and shareholder approval; the target is the fourth quarter of 2026 (Nostrum 2026a).
This structure rules out the easiest valuation error. The sale cheque is not distributable cash. It enters a priority waterfall. At H1, notes payable comprised US$761.9 million of principal and accumulated interest. Gross sale proceeds plus unrestricted cash total about US$459.0 million. The simple deficit is US$302.9 million:
| Transaction waterfall at 30 June 2026 | US$m |
|---|---|
| Gross agreed sale consideration | 304.6 |
| Unrestricted cash | 154.4 |
| Total gross resources before adjustments and costs | 459.0 |
| Notes payable and accumulated interest | (761.9) |
| Simple creditor shortfall | (302.9) |
The calculation is author-computed from the sale announcement and H1 accounts. It is deliberately favourable to equity. It assumes all unrestricted cash remains available, no other creditor ranks ahead, the purchase price suffers no downward adjustment, and transaction, tax and wind-down costs are zero. Each real-world correction moves the residual down.
The company specifies an initial repayment sequence rather than claiming that the named payments settle all noteholder claims. Repaying roughly US$244 million of secured principal, US$150 million of unsecured notes and the tender can use most of the disclosed resources while still leaving hundreds of millions of unsecured claims. A press release can describe how the first dollars move. Ordinary equity depends on what happens to the last dollar.
Four years of production decline sit behind the exit
Nostrum produces oil, condensate, LPG and dry gas in north-west Kazakhstan. Its core Chinarevskoye field feeds an owned gas treatment facility with 4.2 billion cubic metres of annual capacity. The plant can also process third-party feedstock, an important source of revenue as the mature field declines. Stepnoy Leopard added a second resource base, with an 80% working interest and 110 mmboe of reported 2P reserves after appraisal.
The asset story looked better in reserve terms than in cash terms. Total 2P reserves rose from 23.2 mmboe in 2023 to 128 mmboe in 2024 after Stepnoy Leopard was booked. Yet titled production slipped from 13,200 boepd in 2022 to 10,091 in 2023, 10,064 in 2024, 8,562 in 2025 and 6,182 from Chinarevskoye in H1 2026. The new reserve base required development capital that the balance sheet could not supply on ordinary terms (Nostrum 2022; Nostrum 2023; Nostrum 2024; Nostrum 2025; Nostrum 2026b).
| Period | Revenue (US$m) | EBITDA (US$m) | Operating cash flow (US$m) | Capital spending (US$m) | Cash (US$m) | Gross notes (US$m) | Production (boepd) | 2P reserves (mmboe) |
|---|---|---|---|---|---|---|---|---|
| FY2022 | 199.7 | 115.7 | 102.2 | 14.8 | 233.6 | 1,396.5 | 13,200 | 28.0 |
| FY2023 | 119.6 | 42.1 | (2.2) | 17.3 | 161.7 | 471.7 | 10,091 | 23.2 |
| FY2024 | 137.1 | 42.1 | 33.1 | 32.5 | 150.4 | 571.4 | 10,064 | 128.0 |
| FY2025 | 118.0 | 40.1 | 13.5 | 22.9 | 143.3 | 701.8 | 8,562 | 122.0 |
| H1 2026 | 72.6 | 27.7 | 22.6 | 1.9 | 154.4 | 761.9 | 6,182 | not updated |
Revenue, EBITDA, operating cash flow, cash, notes and production are company-reported. Capital spending is author-assembled from purchases of property, plant and equipment plus exploration and evaluation expenditure where separately disclosed. The FY2024 reserve jump is real but not comparable with field decline at Chinarevskoye: it reflects the addition of Stepnoy Leopard, not a reversal in production from the original asset.
The 2023 debt restructuring also makes the gross-notes line look better than the underlying economics. Notes payable fell from US$1.40 billion at December 2022 to US$471.7 million at December 2023 after a debt-to-equity exchange and accounting remeasurement. They then grew to US$571.4 million, US$701.8 million and US$761.9 million as payment-in-kind interest and finance costs accumulated. Debt relief created time. It did not create enough operating cash to stop the stack rebuilding.
The gas plant slowed the decline, but did not repair owner cash
The gas treatment facility is Nostrum's strongest operating asset. It is difficult and expensive to replicate, sits near producing fields, and can process third-party gas. In H1 2026, third-party processing contributed US$8.1 million of revenue. Ural Oil & Gas feedstock also helped lift gas and LPG volumes, while higher Brent prices raised total H1 revenue 13.3% to US$72.6 million. EBITDA rose to US$27.7 million (Nostrum 2026b).
That infrastructure moat is stable. The field moat is eroding. Workovers, compression and plant availability can slow decline, but the titled production trend has continued downward. Management's own 2025 report described a maturing asset base. Unit operating cost per processed barrel equivalent fell to US$7.7 in 2024 and US$6.2 in 2025, helped by cost control and third-party volumes, but lower costs did not overcome shrinking own production and rising finance expense (Nostrum 2024; Nostrum 2025).
Stepnoy Leopard offered a route out. The 2024 reserve booking expanded reported 2P reserves to 128 mmboe, and the field sits within reach of Nostrum's processing infrastructure. The difficulty was sequencing. Development needed money before it could provide production. At the same time, the notes were compounding, Chinarevskoye was declining, and the group had to preserve cash for coupons and creditor negotiations. A resource can be valuable at the asset level while carrying no value for the ordinary share class that lacks funding control.
KazMunayGas provides a useful contrast rather than a direct valuation peer. The national company has integrated upstream, transport and refining operations, state backing and access to capital that a small single-country producer does not. Its 2025 reporting shows how Kazakhstan hydrocarbons can support large-scale cash generation, but those economics do not migrate through Nostrum's capital structure (KazMunayGas 2025).
The macro tape was not the reason for Monday's collapse. The International Energy Agency's August report put North Sea Dated crude near US$92 a barrel after severe Middle East and Caspian disruptions, even as it cut 2026 demand expectations. Strong oil prices helped H1 revenue. The share still fell because the sale crystallised who owns the enterprise value (IEA 2026).
Cash generation weakened before creditors took control
EBITDA overstates what was available to owners. The useful bridge begins with reported operating cash flow, subtracts purchases of property, plant and equipment, and also subtracts exploration and evaluation spending. On that basis, author-computed pre-financing owner cash was about US$87.4 million in 2022, negative US$19.5 million in 2023, positive US$0.5 million in 2024 and negative US$9.4 million in 2025.
| Year | Operating cash flow (US$m) | PPE and field spending (US$m) | Author-computed pre-financing owner cash (US$m) |
|---|---|---|---|
| FY2022 | 102.2 | 14.8 | 87.4 |
| FY2023 | (2.2) | 17.3 | (19.5) |
| FY2024 | 33.1 | 32.5 | 0.5 |
| FY2025 | 13.5 | 22.9 | (9.4) |
The bridge is not free cash flow reported by Nostrum. It is an author calculation. It also excludes 2023's US$19.3 million acquisition payment for Positive Invest and excludes financing costs. Including either would make the cash available to ordinary owners lower.
FY2022 was the outlier because commodity realisations and production were stronger. By 2023, revenue had fallen 40% and tax payments helped push operating cash flow below zero. FY2024 recovered, but most operating cash went back into the asset base, including Chinarevskoye drilling and Stepnoy Leopard appraisal. FY2025 cash generation weakened again while note balances rose by about US$130 million.
H1 2026 looked better on the surface. Operating cash flow was US$22.6 million and capital repairs were light. But finance costs reached US$86.4 million in six months, more than total revenue. Most were non-cash accruals and fair-value amortisation, yet that does not make them irrelevant. The unpaid or capitalised claim sits ahead of shareholders. Total comprehensive loss was US$71.6 million, and attributable equity was negative US$377.7 million (Nostrum 2026b).
Capital allocation became creditor allocation. Management preserved liquidity, delayed coupons under consent arrangements, paid fees to obtain waivers, and sought maturity extensions. Those steps were rational for survival. They also show why a conventional reinvestment story no longer fits. The decisive capital decision is the sale and debt settlement, not how many workovers generate an incremental barrel.
Bondholders, not shareholders, set the economics
Nostrum's 2023 restructuring exchanged a large portion of old debt for new securities and shares. Ordinary shareholders gained a continuing quoted instrument, but creditors retained economic control through secured and unsecured notes. The later increase in principal through payment-in-kind coupons transferred more of the enterprise claim to the debt stack each period.
At June 2026, unrestricted cash covered only about one fifth of notes payable. The group had secured and unsecured notes due on 30 June before interim extensions and restructuring arrangements. Its going-concern assessment depended on creditor support, refinancing and continued operating performance. That is balance-sheet survivability by negotiation, not by internally generated cash.
The asset sale is the end point of that process. Secured creditors are repaid first. Unsecured noteholders receive the specified US$150 million repayment, tender cash and whatever treatment is agreed for remaining claims. Other liabilities, taxes, advisory fees and wind-down costs also require cash. Shareholders receive only the excess after every senior claim is satisfied.
The anti-thesis deserves a fair hearing. The filed US$761.9 million notes balance is not the same thing as cash needed to settle it. Creditors may accept a large discount, tender prices can retire more face value than cash paid, and a buyer might assume selected liabilities. Purchase-price adjustments could also move upward. A failed sale would leave shareholders exposed to operating assets with 122 mmboe of reported 2P reserves rather than a cash shell.
Those possibilities explain option value. They do not reverse the starting deficit. To support the £4.1 million closing market capitalisation through a full cash recovery, total asset value available after existing cash would need to reach roughly US$613 million at the 17 August GBP/USD rate. That is just over twice the agreed US$304.6 million sale price. A modest tender discount cannot bridge the difference.
A sale waterfall replaces the conventional DCF
Discounting future field cash flow is the wrong primary method after a signed agreement to divest the entire operating perimeter and wind down the parent. The relevant model is a completion-and-claims waterfall. A field DCF remains useful only for the break and competing-bid cases.
Conversion uses £0.7382 per US dollar from the 17 August GBP/USD cross-rate (Yahoo Finance 2026). The native dollar waterfall is translated only after creditor claims have been deducted, so currency conversion cannot turn a negative residual into ordinary-equity value.
Nostrum had 165.245 million ordinary shares at H1. The official LSE close was £0.025 per share (2.5p), implying an author-computed market capitalisation of £4.13 million. The LSE page displayed a stale £6.60 million instrument capitalisation consistent with the prior 4.0p close, so this article uses closing price multiplied by the filed share count and labels the calculation rather than repeating the stale field (LSE 2026; Nostrum 2026b).
The reverse valuation is stark. Add the dollar value of the current £4.13 million equity to H1 net debt and the operations need to produce about US$613.1 million before costs for today's ordinary equity to be covered in full. The agreed price is US$304.6 million. The gap between those two figures is about US$308.5 million.
| Waterfall sensitivity | Lower | Middle | Upper |
|---|---|---|---|
| Gross sale value (US$m) | 280 | 304.6 | 350 |
| Unrestricted cash available (US$m) | 130 | 154.4 | 170 |
| Transaction, tax and wind-down leakage (US$m) | 35 | 20 | 10 |
| Notes and senior claims (US$m) | 780 | 761.9 | 700 |
| Residual before ordinary equity (US$m) | (405) | (322.9) | (190) |
The table is author-estimated and intentionally simple. The middle case subtracts US$20 million of leakage from gross resources, making the deficit larger than the US$302.9 million face-value bridge. Even the upper case, which raises consideration, adds cash and assumes lower claims, remains deeply negative. The two variables that matter most are not Brent and production. They are total claims extinguished per dollar paid and net sale proceeds after adjustments.
Monday's 37.5% fall therefore looks like an under-reaction if the signed sale completes on management's stated terms. The market has not valued a positive cash distribution. It has placed £4.1 million on the chance that the final legal and creditor outcome differs from the board's current expectation.
Four paths put 2.5p between a wind-down and a rescue
The severe-downside case is 0-0.1p per share. The sale completes at or below US$304.6 million, costs absorb available slack, and creditors retain every dollar. A token quote may persist while cancellation and wind-down mechanics run, but there is no economic distribution to ordinary holders.
The bear case is 0.1-0.5p. Completion accounts are not adverse, tender mechanics retire debt efficiently and the shell retains a minor claim or cash buffer. The creditor deficit remains much larger than any residual. This case gives the quoted instrument administrative or litigation option value, not asset backing.
The base case is 0.5-1.5p. It assumes a negotiated compromise leaves a modest contingent residual despite the board's no-material-amount expectation. This requires unsecured creditors to concede more than the current disclosure implies. The range remains below 2.5p because a US$303 million starting gap is too large for ordinary completion adjustments to solve.
The bull case is 4-9p. A competing proposal, substantial repricing, debt-forgiveness package or failed-sale refinancing closes most of the gap and preserves the operating option. The low end equates to roughly £6.6 million of equity; the high end to about £14.9 million. Those are small values beside the creditor stack, but achieving them still requires enterprise proceeds above US$610 million or a concession with similar economic effect.
These ranges are not probability-weighted and were not arranged around the closing price. The 2.5p quote sits above the base range and below the bull range. That placement says the market is paying for rescue optionality. It does not contradict the company's view that the agreed transaction leaves no material shareholder recovery.
The transaction documents now matter more than the reserve report
The shareholder circular is the next decisive document. It should specify purchase-price adjustments, locked-box or completion-account mechanics, tax allocation, assumed and excluded liabilities, termination rights, break fees, regulatory conditions and the exact use of proceeds. It should also explain what remains in the UK parent after the four subsidiaries leave. Until then, the US$302.9 million shortfall is a strong directional measure rather than a final liquidation account.
The unsecured-note tender is the second evidence point. Cash paid is less important than face claims retired. A tender that spends US$30 million to cancel US$30 million of claims barely changes the deficit. The same cash retiring US$60 million helps, but still leaves the ordinary class far out of the money. The threshold in this article is a reduction of at least 40% in face claims per dollar of cash used before the tender materially changes the equity argument.
Regulatory and lender consents follow. A delay beyond Q4 adds interest, advisory cost and deal-break risk. It could increase the option value of continued operations, but it also consumes liquidity and leaves the group dependent on creditor forbearance. Deal failure is not automatically favourable to equity.
Operational data have become secondary but not irrelevant. Chinarevskoye production below 5,500 boepd, a deterioration in third-party processing or unrestricted cash below US$130 million would weaken the break case. A durable increase in Ural Oil & Gas feedstock and a funded Stepnoy Leopard plan would support it. Neither changes priority while the notes remain outstanding.
Source notes: confidence and missing information
Verification is full for identity, the triggering announcement, closing move, five-period financial history and the filed H1 balance sheet. Overall verification is marked partial because the independent DealFlow page became unavailable during the final liveness check after it had been fetched and read earlier in the run. The Finance API health and authentication preflight passed, but the exact resolver returned no LSE:NOG match, so it provided no quote, filings or facts packet for this instrument. The article therefore uses the LSE, Companies House and fetched company filings and records that unsupported sidecar result rather than substituting another venue.
The largest missing items are the transaction circular, detailed closing adjustment formula, creditor settlement agreements, current cash outside the sold subsidiaries, tax leakage and wind-down budget. The buyer's financing is not disclosed. The sale price cannot be treated as certain until conditions are satisfied. Independent reporting confirms the announced terms but does not add private deal detail (DealFlow Intel 2026).
The evidence available now is enough for one conclusion. The operating assets found a US$304.6 million buyer, but H1 net debt was about US$607.5 million. Monday's fall recognised that gap. At 2.5p, the remaining quote prices a departure from the disclosed creditor-led wind-down. The shareholder circular and tender result will show whether that option has substance or merely a ticker.
References
- Nostrum 2026a. Nostrum Oil & Gas PLC, Agreement for the disposal of Kazakhstan operations, 17 August 2026.
- DealFlow Intel 2026. Nostrum Oil & Gas transaction with GR Fairy, 17 August 2026.
- LSE 2026. London Stock Exchange, Nostrum Oil & Gas PLC company and market page, 17 August 2026 close.
- Companies House 2026. Companies House, Nostrum Oil & Gas PLC company record 08717287.
- Nostrum 2022. Nostrum Oil & Gas PLC, Annual Report and Accounts 2022.
- Nostrum 2023. Nostrum Oil & Gas PLC, Annual Report and Accounts 2023.
- Nostrum 2024. Nostrum Oil & Gas PLC, Annual Report and Accounts 2024.
- Nostrum 2025. Nostrum Oil & Gas PLC, Annual Report and Accounts 2025.
- Nostrum 2026b. Nostrum Oil & Gas PLC, Interim Financial Report H1 2026.
- Nostrum summary 2026. Nostrum Oil & Gas PLC, Summary financials and operating history.
- Yahoo Finance 2026. GBP/USD market quote, 17 August 2026.
- IEA 2026. International Energy Agency, Oil Market Report, August 2026.
- KazMunayGas 2025. KazMunayGas NC JSC, Annual Report 2025.